Non-exclusive voluntary licensing outside of HIV/AIDS

Bristol-Myers Squibb, Gilead
Gilead and Bristol-Myers Squibb take the first moves, from companies in scope of the Access to Medicine Index 2016, outside non-exclusive voluntary licensing in HIV/AIDS.
Continue reading

The Quick-Start initiative

Bristol-Myers Squibb
Bristol-Myers Squibb is involved in the launch of an innovative structured donation programme aimed at curing hepatitis C.
Continue reading